SEC recommends Phase 1 clinical trials of Reliance's Covid Vaccine candidate

Aug 27, 2021

New Delhi [India], August 27 : The Subject Expert Committee (SEC) has recommended Phase 1 clinical trials of Reliance's recombinant COVID-19 vaccine candidate.

Subject expert committee recommends Russia's Sputnik Light one-shot COVID-19 vaccine: Sources

Feb 04, 2022

New Delhi [India], February 5 : The subject expert committee under India's drug regulator has recommended Russia's Sputnik Light one-shot COVID-19 vaccine, sources told...

DCGI's expert panel to review Phase III data of Covaxin today

Jun 22, 2021

New Delhi [India], June 22 : The Subject Expert Committee (SEC) under the drug regulator will discuss reviewing the Phase III data of Bharat...

No recommendations for COVID-19 booster dose by SEC: Sources

Dec 11, 2021

New Delhi [India], December 11 : The Subject Expert Committee (SEC) under Central Drugs Standard Control Organization (CDSCO) has said COVID-19 that booster doses...

Expert panel likely to take call on Sputnik V vaccine at key meet today

Apr 12, 2021

New Delhi [India], April 12 : The Subject Expert Committee (SEC) is likely to meet today to take up Sputnik V application for Emergency...

Expert Committte demands additional information from Sputnik V on EUA in India

Apr 01, 2021

New Delhi [India], April 1 : Russia's COVID-19 Sputnik V vaccine was denied emergency use authorisation in India on Thursday by the Subject...